Skip to main content
. 2022 Nov 2;42(12):1093–1100. doi: 10.1007/s40261-022-01210-1

Fig. 1.

Fig. 1

Pharmacokinetic profile of parent drug and two main metabolites (M1 and M2) after six once-weekly subcutaneous doses of glepaglutide 5 mg (a) and glepaglutide 10 mg (b). Nominal times used